Loading...
Sinopharm Group Co. Ltd.
SHTDY•PNK
Healthcare
Medical - Distribution
$13.00
$0.02(0.12%)
U.S. Market opens in 13h 43mSinopharm Group Co. Ltd. (SHTDY) AI-Powered Stock Analysis
See how Sinopharm Group Co. Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerSinopharm Group Co. Ltd. (SHTDY) Stock Overall Grade
Sinopharm Group Co. Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Sinopharm Group Co. Ltd.'s overall stock rating.
Forecast
BScore
65/100Financial Growth
B+Score
70/100Fundamental Growth
BScore
62/100Key Ratios
AScore
83/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100Sinopharm Group Co. Ltd. (SHTDY) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 65/100 (B), reflecting high confidence in its potential. Financial Growth (70/100, B+) and Fundamental Growth (62/100, B) highlight its stability, while Key Ratios (83/100, A) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Sinopharm Group Co. Ltd. stock grade, including financials, comparisons, and forecasts.